Welcome to our dedicated page for SWK Holdings Corporation news (Ticker: SWKH), a resource for investors and traders seeking the latest updates and insights on SWK Holdings Corporation stock.
SWK Holdings Corporation (Nasdaq: SWKH) is a specialized finance company providing capital solutions primarily to the life sciences sector. The core focus of SWK is to monetize cash flow streams derived from commercial-stage products and intellectual properties. Through royalty purchases, financings, and synthetic revenue interests, SWK offers innovative financial structures aimed at minimizing equity dilution for its partners.
The company operates under two main segments: Finance Receivables and Pharmaceutical Development Services. The Finance Receivables segment generates the majority of the revenue, primarily through interest, fees, and royalties from various financing activities. SWK's financing solutions are designed to support the growth and commercialization efforts of small to mid-sized healthcare companies while maintaining low risk.
Recent achievements include the generation of $7.6 million in adjusted non-GAAP net income from the finance segment in Q2 2023, representing a 12% annualized return on tangible book value. The portfolio yield stands at an effective 14.5% and a realized 15.4%. The company expects continued growth in finance receivables, driven by multiple loan closings anticipated in the second half of 2023.
SWK also owns Enteris BioPharma, a clinical development and manufacturing organization. Enteris provides development services to pharmaceutical partners and offers innovative formulation solutions via its Peptelligence® platform. Enteris has booked $2.0 million in CDMO projects and is bidding on an additional $9.0 million worth of work projected to drive revenue growth in the latter half of 2023.
Financially, SWK's total revenue for Q2 2023 reached $9.5 million, marking a 36.8% increase year-over-year. The GAAP net income surged to $3.9 million, a 596.3% increase from the previous year. Additionally, the company reported a book value per share of $21.79 as of June 30, 2023, with an 8% year-over-year increase in non-GAAP tangible financing book value per share.
SWK continues to expand its financial capacity with a new $30 million offering of 9.00% Senior Notes due in 2027 and an expanded $60 million revolving credit facility. This capital will support further acquisitions, investments, and other general corporate purposes, enabling SWK to maintain its leadership in healthcare finance.
SWK Holdings Corporation (SWKH) announced significant corporate changes and financial results for Q4 2022. Jody Staggs has been named CEO, and Laurie Dotter will chair the board. The company expects quarterly operating expenses to decrease by over $1 million by Q3 2023. Q4 revenue fell 34.5% to $9.8 million, primarily due to a reduction in Pharmaceutical Development revenue. GAAP net income was $2.8 million, down from $6.3 million YoY, reflecting a pre-tax loss of $4.4 million. Investment assets increased by 25.4% to $237.9 million. The company remains focused on sustainable growth within the life sciences sector.
SWK Holdings Corporation (Nasdaq: SWKH), a specialty finance firm focused on life sciences, is set to host a conference call and live audio webcast on April 3, 2023, at 10:00 a.m. ET. The call will cover the corporate and financial results for the fourth quarter and full year of 2022. Interested investors can participate by calling (844) 378-6488 (U.S.) or (412) 317-1079 (International), or by accessing the webcast on the company's website. SWK specializes in non-dilutive financing for small- and mid-sized healthcare companies, providing flexible funding solutions ranging from $5.0 million to $25.0 million.
SWK Holdings Corporation (SWKH) announced the appointment of Jerry Albright to its Board of Directors, effective March 15, 2023, replacing Wendy DiCicco, who opted not to seek re-election due to external commitments. Mr. Albright brings extensive experience from his roles at the Teacher Retirement System of Texas and as managing partner at ADIM, LLC. His expertise is expected to enhance SWK's strategic goals in providing non-dilutive financing for small and mid-sized healthcare companies. The transition is aimed at maximizing SWK’s position in the market amid favorable capital dynamics.
DEWALT, a Stanley Black & Decker brand, will unveil innovative products at the World of Concrete Trade Show from January 17-19 in Las Vegas. Key launches include the 60V MAX* Cordless SDS MAX Chipping Hammer and 60V MAX* Cordless Breaker Hammer, both designed for heavy-duty demolition, available in July 2023. Also featured are the 60V MAX* Large Angle Grinder and TOUGHSYSTEM® 2.0 Dual Port Charger, scheduled for release in June and February 2023, respectively. Additional offerings include a 10 Gallon Dust Extractor and the PURE220+™ Premium Epoxy Anchor.
SWK Holdings Corporation (Nasdaq: SWKH) has officially named Jody Staggs as Chief Executive Officer, effective January 1, 2023, following his role as interim CEO since September 2022. Staggs' leadership has already facilitated multiple financing initiatives and improvements to the company's credit facility. Additionally, Laurie Dotter has been appointed Chair of the Board, contributing her extensive experience from various investment firms. Staggs emphasized a focus on optimizing capital structure and enhancing non-dilutive financial offerings for small and mid-sized life science companies.
SW K Holdings Corporation (Nasdaq: SWKH) announced a significant amendment to its Loan and Security Agreement with Cadence Bank, boosting its credit facility to $35 million, with an option to increase to $50 million. The new terms offer a lower interest rate of SOFR plus 2.65% and set a maturity date of September 30, 2025. This enhancement is part of SWK's strategy to optimize its capital structure and respond to rising interest in its non-dilutive financing solutions aimed at small- and mid-sized life sciences companies.
sbLiftOff, a mergers and acquisitions advisory firm, announced the appointment of Army veteran Branden Irvine as Director of Sales and Marketing. Irvine, a Bronze Star awardee, brings extensive experience from top brands including Stanley Black and Decker. His leadership aims to enhance sbLiftOff's services for government contracting and founder-led businesses. The firm specializes in mergers and acquisitions, particularly assisting veteran-owned businesses. The announcement highlights Irvine's commitment to supporting companies throughout their growth and acquisition journeys.
SWK Holdings Corporation (Nasdaq: SWKH) reported a 195% increase in GAAP net income to $6.6 million or $0.51 per diluted share for Q3 2022. Revenue rose 42.4% year-over-year to $13.6 million, driven by milestone revenue from its partnership with Cara Therapeutics. The finance portfolio effective yield was 14.3%, with a realized yield of 17.5%. The company closed three transactions totaling $57.5 million and repurchased 34,463 shares for $0.6 million. Notably, non-GAAP adjusted net income was $8.3 million, a 94.8% increase over the previous year.
SWK Holdings Corporation (NASDAQ: SWKH) will host a conference call on November 10, 2022, at 10:00 a.m. ET to discuss its third quarter 2022 financial results. The call can be accessed via phone or audio webcast, with an archive available for 90 days post-event. SWK Holdings is a specialty finance company focused on small- and mid-sized healthcare companies, providing non-dilutive financing solutions that typically range from $5 million to $25 million. The Company aims to create long-term value for stakeholders through unique financing structures.
Stanley Black & Decker (NYSE: SWK) will host a live webcast on November 9, 2022, at 9:30 AM ET, featuring a presentation by President and CEO Don Allan during the Baird 2022 Industrial Conference in Chicago, IL. The webcast can be accessed via the Investors section of their website, with a replay available for 30 days. As a leading global tool company, Stanley Black & Decker employs around 60,000 people and is known for its innovative brands like DEWALT and BLACK+DECKER.
FAQ
What is the current stock price of SWK Holdings Corporation (SWKH)?
What is the market cap of SWK Holdings Corporation (SWKH)?
What does SWK Holdings Corporation do?
What are the primary segments of SWK Holdings?
How does SWK generate most of its revenue?
What recent financial milestones has SWK achieved?
What is Enteris BioPharma?
How is SWK expanding its financial capacity?
What was the effective and realized portfolio yield for SWK in Q2 2023?
What are SWK's plans for the second half of 2023?
What is the focus of SWK's financing solutions?
How can investors access SWK's conference calls and webcasts?
